In this context, Gal-3 appears to function both as a biomarker and as a causal factor in the development of heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF)/ heart failure with mid-range ejection fraction (HFmrEF) in this setting [37]. This evidence concerns the gene LGALS3 and heart failure.